FINANCIALS

KYMR Kymera Therapeutics Inc 1815442

Income Statement
Revenue	kymr-20241231	47,072,000
Net Income	kymr-20241231	-223,858,000
Profit Margin		-475.57%

Balance Sheet
Current Assets	510,268,000
Assets	978,035,000
Current Liabilities	67,767,000
Liabilities	142,416,000
Equity	835,619,000
Shares Out	63,756,000

Cash Flow Statement
Operating Cash Flow	-194,501,000
Investing Cash Flow	-404,077,000

Market Analysis
Market Cap	3,092,949,370
Price	33.62
BVPS	13.11
PB	2.56
EPS	-2.41
PS	16.43
FCF	-598,578,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view KYMR documents filed with the SEC.

KYMR Filings Clear

View A List of Tickers